Skip to main content
. Author manuscript; available in PMC: 2010 Apr 16.
Published in final edited form as: J Neuroimmune Pharmacol. 2009 Mar 3;4(2):249–259. doi: 10.1007/s11481-009-9148-4

Fig. 8.

Fig. 8

Effects of drug treatment on blood flow during cerebral ischemic/reperfusion injury. The CB2 receptor agonist O-1966 (1 mg/kg), the CB1 receptor antagonist (SR141716A) (5 mg/kg), the CB2 receptor antagonist (SR141528) (5 mg/kg), or a combination of O-1966 and the CB1 receptor antagonist were given prior to occlusion. Blood flow was evaluated using laser Doppler measurements. N=6. *p<0.05 (from Zhang et al. 2008)